Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > How should this be graded in the weekly report card?

<< Previous

Bullboard Posts

Next >>

Comment by scarlet1967on Jun 15, 2021 2:07pm

102 Views

Post# 33389415

RE:RE:RE:RE:RE:RE:RE:RE:RE:How should this be graded in the weekly report card?

Dr. Grinspoon and his team seems to have been involved with GLI/NASH council for a while.

"There are currently more than 70 members of the NASH Council including the American Association for the Study of Liver Diseases (AASLD), the Endocrine Society, the Obesity Action Center (OAC), the American Cancer Society, the American Heart Association, the American Gastroenterological Association (AGA), the American College of Physicians, the American Nursing Association, Duke University School of Medicine, University of California San Francisco Medical Center, Massachusetts General Hospital/ Harvard Medical School: Fatty Liver Disease Clinic, Fatty Liver Foundation, NASH kNOWledge, the Liver Forum, and more."

https://static1.squarespace.com/static/53bafd3ce4b0ae714af7153f/t/5fdcc2f037b4b658917832f3/1608303368832/us-nash-action-plan-global-liver-institute-nash-council.pdf

qwerty22 wrote: https://www.theratech.com/news-releases/news-release-details/virtual-panels-nash-organized-global-liver-institute

Involving themselves with the Global Liver Institute is a smart move. The woman running that seems like a very well connected person.

Dr. Grinspoon and his team seems to have been involved with GLI/NASH council for a while.

There are currently more than 70 members of the NASH Council including the American Association for the Study of Liver Diseases (AASLD), the Endocrine Society, the Obesity Action Center (OAC), the American Cancer Society, the American Heart Association, the American Gastroenterological Association (AGA), the American College of Physicians, the American Nursing Association, Duke University School of Medicine, University of California San Francisco Medical Center, Massachusetts General Hospital/ Harvard Medical School: Fatty Liver Disease Clinic, Fatty Liver Foundation, NASH kNOWledge, the Liver Forum, and more.

https://static1.squarespace.com/static/53bafd3ce4b0ae714af7153f/t/5fdcc2f037b4b658917832f3/1608303368832/us-nash-action-plan-global-liver-institute-nash-council.pdf

<< Previous

Bullboard Posts

Next >>

DRI Healthcare stock drops 28% after executive changes